Randomized trials of dichlorphenamide in the periodic paralyses

Annals of Neurology

Volumn 47, Issue 1, 2000, Pages 46-53

  Tawil, Rabi ^a   McDermott, Michael P ^a   Brown Jr , Robert ^b   Shapiro, Barbara C ^b   Ptacek, Louis J ^c   McManis, Philip G ^d   Dalakas, Marinos C ^e   Spector, Sidney A ^e   Mendell, Jerry R ^f   Hahn, Angelika F ^g   Griggs, Robert C ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DICLOFENAMIDE; PLACEBO; POTASSIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DISORIENTATION; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKING; MULTICENTER STUDY; PERIODIC PARALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKELETAL MUSCLE; STATISTICAL ANALYSIS; THINKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; DICHLORPHENAMIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PARALYSIS; PROGNOSIS; TIME FACTORS;

EID: 0033958202     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H     Document Type: Article

References (16)

1. Tawil R. The periodic paralyses and associated disorders. In: Gilman S, Goldstein GW, Waxman SG, eds. Neurobase. 2nd ed. San Diego: Arbor Publishing, 1999
2. Tawil R, Griggs RC. Hypokalemic periodic paralysis. In: Lane RJM, ed. Handbook of muscle disease. New York: Marcel Dekker, 1996:329-337
3. Mendell JR, Griggs RC, Ptacek LJ. Diseases of muscle. In: Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:2473-2483
4. Resnick JS, Engel WK, Griggs RC, Stam AC. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1969;278:582-586
5. Griggs RC, Engel WK, Resnick JS. Acetazolamide treatment of hypokalemic periodic paralysis: prevention of attacks and improvement of persistent weakness. Ann Intern Med 1970;73: 39-48
6. Dalakas MC, Engel WK. Treatment of "permanent" muscle weakness in familial periodic paralysis. Muscle Nerve 1983;6: 182-186
7. Torres CF, Griggs RC, Moxley RT, Bender AN. Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology 1981;31:1423-1428
8. The Guillain Barré Syndrome Study Group. Plasmapheresis and acute Guillain Barré syndrome. Neurology 1985;35:1096-1104
9. Mainland D. Elementary medical statistics. 2nd ed. Philadelphia: WB Saunders, 1963
10. Gart JJ. An exact test for comparing matched proportions in crossover designs. Biometrika 1969;56:75-80
11. Agresti A. Categorical data analysis. New York: John Wiley, 1990
12. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972: 28:577-584
13. Lichter PR, Newman LP, Wheeler NC, Beall OV. Patient tolerance to carbonic anhydrase inhibitors. Am J Ophthalmol 1978;85:495-502
14. Garrison L, Roth A, Rundle H, et al. A clinical comparison of three carbonic anhydrase inhibitors. Trans Pacif Coast Otoophthalmol Soc 1967;51:137-145
15. Benjamin KW. Toxicity of ocular medications. Int Ophthalmol Clin 1979;19:199-255
16. Griggs RC, Ptacek LJ. Mutations of sodium channels in petiodic paralysis: can they explain the disease and predict treatment? Neurology 1999;52:1309-1310